Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Madhusudhan Kollareddy - , University of Mississippi (Author)
  • Elizabeth Dimitrova - , University of California at Los Angeles (Author)
  • Krishna C. Vallabhaneni - , University of Mississippi (Author)
  • Adriano Chan - , University of California at San Diego (Author)
  • Thuc Le - , University of California at Los Angeles (Author)
  • Krishna M. Chauhan - , University of Mississippi (Author)
  • Zunamys I. Carrero - , University of Mississippi (Author)
  • Gopalakrishnan Ramakrishnan - , University of Mississippi (Author)
  • Kounosuke Watabe - , University of Mississippi, Wake Forest University (Author)
  • Ygal Haupt - , Peter Maccallum Cancer Centre, University of Melbourne (Author)
  • Sue Haupt - , Peter Maccallum Cancer Centre, University of Melbourne (Author)
  • Radhika Pochampally - , University of Mississippi (Author)
  • Gerard R. Boss - , University of California at San Diego (Author)
  • Damian G. Romero - , University of Mississippi (Author)
  • Caius G. Radu - , University of California at Los Angeles (Author)
  • Luis A. Martinez - , University of Mississippi (Author)

Abstract

Mutant p53 (mtp53) is an oncogene that drives cancer cell proliferation. Here we report that mtp53 associates with the promoters of numerous nucleotide metabolism genes (NMG). Mtp53 knockdown reduces NMG expression and substantially depletes nucleotide pools, which attenuates GTP-dependent protein activity and cell invasion. Addition of exogenous guanosine or GTP restores the invasiveness of mtp53 knockdown cells, suggesting that mtp53 promotes invasion by increasing GTP. In addition, mtp53 creates a dependency on the nucleoside salvage pathway enzyme deoxycytidine kinase for the maintenance of a proper balance in dNTP pools required for proliferation. These data indicate that mtp53-harbouring cells have acquired a synthetic sick or lethal phenotype relationship with the nucleoside salvage pathway. Finally, elevated expression of NMG correlates with mutant p53 status and poor prognosis in breast cancer patients. Thus, mtp53's control of nucleotide biosynthesis has both a driving and sustaining role in cancer development.

Details

Original languageEnglish
Article number7389
JournalNature communications
Volume6
Publication statusPublished - 12 Jun 2015
Peer-reviewedYes
Externally publishedYes

External IDs

PubMed 26067754
ORCID /0000-0001-8501-1566/work/173989183